Tempus lab is a fast-growing technology firm that has built an operating system to battle against cancer disease. The primary mission is to redefine the use of clinical and molecular data in a healthcare setting. As the organization accumulates the collected data, the treatments of patients who come after diagnosis are advantaged because physician got useful tools from the previously received data.
Tempus is a rapidly growing company in Chicago that appeared in the top ten ranking, and as a matter of fact, it has built medical research labs for data analytics setup that requires medical professionals to operate. Tempus has raised $80 million in the fund round on March 2018, hence, bringing a total value of $1.1 billion to the company in a period less than one and half years. March rounds initiated by the new investors and the existing investors.
The organization estimates a total of $210 million investment in two years after being founded. New Enterprise Associates is the prominent investing company who has invested in firms co-founded by Lefkofsky and in the latest funds, Brad Keywell, a business partner and Revolution Ventures founder, Steve Case funded along with the Tempus co-founder.
Tempus has initiated a developmental program of building a database library which accommodates and make available of all enough resources for the medical researchers. Unicorn is an operational system for oncologists that enable physicians to use data to figure out cancer treatment process and extend that patients respond to a particular medicine.
Tempus employs about 100 expertise medical practitioners at its River North headquarters and aims at increasing the number by recruiting more software engineers and computational biologists. This healthcare firm contains a genomic sequencing technology lab that processes more than 50,000 patients annually.
Tempus Unicorn has partnered with cancer research hospitals like the Mayo Clinic, the Cleveland Clinic, Northwestern University, the University of Michigan, the University of Chicago, Duke University School of Medicine, Knight Cancer Institute, and the UC Davis Comprehensive Cancer Center. The traction that Tempus made with others in the industry has been well as it currently works with nearly half of all Academic Medical Centers in the United States.
To Learn More Click Here